Is customisation healthcare’s secret weapon? 

Stem cells

This is the latest episode of the free narrated DDW podcast, “Is customisation healthcare’s secret weapon?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. The articles are called “Optimising vaccine production through customisation” and “Exploring iPSCs for individual and population health applications”. 

In the first article, “Optimising vaccine production through customisation”, John Yoshi Shyu, Ph.D. Corning Life Sciences offers an expert view on the topic. In the second article, Brad Hamilton, Founder and Chief Science Officer at GoodCell, examines the potential of induced Pluripotent Stem Cells. 

You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free